Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROZANOLIXIZUMAB-NOLI for Myasthenia gravis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 233 adverse event reports in the FDA FAERS database where ROZANOLIXIZUMAB-NOLI was used for Myasthenia gravis.

Most Reported Side Effects for ROZANOLIXIZUMAB-NOLI

Side Effect Reports % Deaths Hosp.
Myasthenia gravis 57 16.3% 0 28
Drug ineffective 51 14.6% 0 11
Headache 48 13.8% 0 11
Nausea 29 8.3% 1 9
Diarrhoea 27 7.7% 1 9
Fatigue 27 7.7% 0 6
Dyspnoea 19 5.4% 1 10
Hospitalisation 19 5.4% 1 19
Vomiting 17 4.9% 1 7
Therapy interrupted 15 4.3% 0 5
Asthenia 14 4.0% 0 8
Off label use 14 4.0% 0 5
Product dose omission issue 13 3.7% 0 7
Pyrexia 13 3.7% 0 5
Dizziness 12 3.4% 0 5

Other Indications for ROZANOLIXIZUMAB-NOLI

Product used for unknown indication (103)

Other Drugs Used for Myasthenia gravis

ECULIZUMAB (5,715) RAVULIZUMAB-CWVZ (3,781) EFGARTIGIMOD ALFA-FCAB (2,291) HUMAN IMMUNOGLOBULIN G (1,758) PYRIDOSTIGMINE (911) RITUXIMAB (805) PREDNISONE (660) MYCOPHENOLATE MOFETIL (655) AZATHIOPRINE (442) PREDNISOLONE (438)

Related Pages

ROZANOLIXIZUMAB-NOLI Full Profile All Myasthenia gravis Drugs ROZANOLIXIZUMAB-NOLI Demographics ROZANOLIXIZUMAB-NOLI Timeline